Pharmacokinetics, Safety and Efficacy of BIA 5-1058 in PAH (Zamicastat)

NCT04316143 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: Oral zamicastat

Sponsor

Bial - Portela C S.A.